In light of promising results of hydroxychloroquine in COVID-19, should we consider using it prophylactically in cancer patients, especially if immunocompromised?

Topics: Radiation Oncology • Pediatric Oncology • Medical Oncology • Rheumatology • COVID-19

Acknowledging that there is no time for good trials yet in this setting

Answer from: at Academic Institution

At this time, as there is no good evidence available, I would not recommend the use of hydroxycholoroquine prophylactically in cancer patients. It is unclear whether it would prevent contagion, probably not, and we still don't know if it will have any effect on the course of COVID-19. We expect ther...

Comments

Radiation Oncologist at Florida International University
I agree that prophylactic use at large is difficul...

Radiation Oncologist at Locum Tenens
No, hydroxychloroquine is probably not an effectiv...

Radiation Oncologist at AV Strauss MD
Now I am really confused. What I am understanding ...

at MD Anderson Cancer Center
More data is needed. I'm hearing anecdotally that ...

Radiation Oncologist at Locum Tenens
@Andrejs V. Strauss I didn't mean to give the impr...

Radiation Oncologist at AV Strauss MD
Thank you for clarifying!!!

Radiation Oncologist at Locum Tenens
@Andrejs V. Strauss I sincerely hope I'm wrong abo...

Radiation Oncologist at AV Strauss MD
I do as well, as I have an immune compromised (med...

Radiation Oncologist at Locum Tenens
@Andrejs V. Strauss Update, April 2 2020. There is...

at MD Anderson Cancer Center
Not a great study for the reasons you point out. D...

Related Questions